triple agonist glp-1 Agonism Based Therapies for Obesity | Current Cardiovascular Risk Reports I'm Worried! Triple Agonist GLP-1

Study aim To identify the specific component of GH secretory pattern responsible for the stimulation of lipolytic rate during fasting in humans

Four weeks later, liraglutide or saline was injected subcutaneously and dissection was performed as above

Primary Research Areas Growth hormone secretion dynamics: Laboratory models exploring synergistic GH release via concurrent activation of GHS-R by Ipamorelin and GHRH receptors by CJC-1295 (no DAC), including studies of GH pulse amplitude and frequency

CEST, Chemical Exchange Saturation Transfer

Ryan DG, Yang M, Prag HA, Blanco GR, Nikitopoulou E, Segarra-Mondejar M, et al